These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25336193)

  • 1. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.
    Adamson D; Blazeby J; Nelson A; Hurt C; Nixon L; Fitzgibbon J; Crosby T; Staffurth J; Evans M; Kelly NH; Cohen D; Griffiths G; Byrne A
    Trials; 2014 Oct; 15():402. PubMed ID: 25336193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT.
    Adamson D; Blazeby J; Porter C; Hurt C; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Byrne A
    Health Technol Assess; 2021 May; 25(31):1-144. PubMed ID: 34042566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial.
    Adamson D; Byrne A; Porter C; Blazeby J; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Hurt C
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):292-303. PubMed ID: 33610215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for dysphagia in oesophageal cancer.
    Dai Y; Li C; Xie Y; Liu X; Zhang J; Zhou J; Pan X; Yang S
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005048. PubMed ID: 25354795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2011 Feb; (2):CD005048. PubMed ID: 21328271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life.
    Madhusudhan C; Saluja SS; Pal S; Ahuja V; Saran P; Dash NR; Sahni P; Chattopadhyay TK
    Dis Esophagus; 2009; 22(4):331-6. PubMed ID: 19473211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of esophageal stenting for management of malignant dysphagia.
    Rao C; Haycock A; Zacharakis E; Krasopoulos G; Yakoub D; Protopapas A; Darzi A; Hanna GB; Athanasiou T
    Dis Esophagus; 2009; 22(4):337-47. PubMed ID: 19207559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
    Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial.
    Javed A; Pal S; Dash NR; Ahuja V; Mohanti BK; Vishnubhatla S; Sahni P; Chattopadhyay TK
    J Gastrointest Cancer; 2012 Mar; 43(1):63-9. PubMed ID: 20835926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study.
    Bergquist H; Johnsson E; Nyman J; Rylander H; Hammerlid E; Friesland S; Ejnell H; Lundell L; Ruth M
    Dis Esophagus; 2012 Jul; 25(5):410-5. PubMed ID: 21899654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy.
    Nicholson DA; Haycox A; Kay CL; Rate A; Attwood S; Bancewicz J
    Clin Radiol; 1999 Apr; 54(4):212-5. PubMed ID: 10210338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial.
    Wenger U; Johnsson E; Bergquist H; Nyman J; Ejnell H; Lagergren J; Ruth M; Lundell L
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1369-77. PubMed ID: 16292092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer.
    Shenfine J; McNamee P; Steen N; Bond J; Griffin SM
    Health Technol Assess; 2005 Feb; 9(5):iii, 1-121. PubMed ID: 15717937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-expanding metal stents versus plastic prostheses in the palliation of malignant dysphagia: long-term outcome of 153 consecutive patients.
    Eickhoff A; Knoll M; Jakobs R; Weickert U; Hartmann D; Schilling D; Eickhoff JC; Riemann JF
    J Clin Gastroenterol; 2005; 39(10):877-85. PubMed ID: 16208111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis.
    Burstow M; Kelly T; Panchani S; Khan IM; Meek D; Memon B; Memon MA
    Dis Esophagus; 2009; 22(6):519-25. PubMed ID: 19302213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-expanding metal stents in palliation of malignant dysphagia: outcome of 124 Egyptian patients.
    Elsharkawy AA; El-Geidie AA
    Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1123-7. PubMed ID: 20069308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study].
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2800-6. PubMed ID: 16385833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial.
    Bergquist H; Wenger U; Johnsson E; Nyman J; Ejnell H; Hammerlid E; Lundell L; Ruth M
    Dis Esophagus; 2005; 18(3):131-9. PubMed ID: 16045572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.